Literature DB >> 17006541

Regulation of TopBP1 oligomerization by Akt/PKB for cell survival.

Kang Liu1, Jason C Paik, Bing Wang, Fang-Tsyr Lin, Weei-Chin Lin.   

Abstract

Regulation of E2F1-mediated apoptosis is essential for proper cellular growth. This control requires TopBP1, a BRCT (BRCA1 carboxyl-terminal) domain-containing protein, which interacts with E2F1 but not other E2Fs and represses its proapoptotic activity. We now show that the regulation of E2F1 by TopBP1 involves the phosphoinositide 3-kinase (PI3K)-Akt signaling pathway, and is independent of pocket proteins. Akt phosphorylates TopBP1 in vitro and in vivo. Phosphorylation by Akt induces oligomerization of TopBP1 through its seventh and eighth BRCT domains. The Akt-dependent oligomerization is crucial for TopBP1 to interact with and repress E2F1. Akt phosphorylation is also required for interaction between TopBP1 and Miz1 or HPV16 E2, and repression of Miz1 transcriptional activity, suggesting a general role for TopBP1 oligomerization in the control of transcription factors. Together, this study defines a novel pathway involving PI3K-Akt-TopBP1 for specific control of E2F1 apoptosis, in parallel with cyclin-Cdk-Rb for general control of E2F activities.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17006541      PMCID: PMC1618094          DOI: 10.1038/sj.emboj.7601355

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  37 in total

1.  Akt and 14-3-3eta regulate Miz1 to control cell-cycle arrest after DNA damage.

Authors:  Michael Wanzel; Daniela Kleine-Kohlbrecher; Steffi Herold; Andreas Hock; Katrien Berns; Jongsun Park; Brian Hemmings; Martin Eilers
Journal:  Nat Cell Biol       Date:  2004-12-05       Impact factor: 28.824

Review 2.  The E2F family: specific functions and overlapping interests.

Authors:  Claire Attwooll; Eros Lazzerini Denchi; Kristian Helin
Journal:  EMBO J       Date:  2004-11-11       Impact factor: 11.598

3.  A simplified system for generating recombinant adenoviruses.

Authors:  T C He; S Zhou; L T da Costa; J Yu; K W Kinzler; B Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

4.  A DNA-topoisomerase-II-binding protein with eight repeating regions similar to DNA-repair enzymes and to a cell-cycle regulator.

Authors:  K Yamane; M Kawabata; T Tsuruo
Journal:  Eur J Biochem       Date:  1997-12-15

5.  Regulation of the cyclin E gene by transcription factor E2F1.

Authors:  K Ohtani; J DeGregori; J R Nevins
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-19       Impact factor: 11.205

6.  Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase.

Authors:  W Krek; M E Ewen; S Shirodkar; Z Arany; W G Kaelin; D M Livingston
Journal:  Cell       Date:  1994-07-15       Impact factor: 41.582

7.  E2F1 is crucial for E2F-dependent apoptosis.

Authors:  Eros Lazzerini Denchi; Kristian Helin
Journal:  EMBO Rep       Date:  2005-07       Impact factor: 8.807

8.  Transcriptional regulation of AKT activation by E2F.

Authors:  Marie Chaussepied; Doron Ginsberg
Journal:  Mol Cell       Date:  2004-12-03       Impact factor: 17.970

9.  Cyclin A/CDK2 binds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/DP-1 by phosphorylation.

Authors:  M Xu; K A Sheppard; C Y Peng; A S Yee; H Piwnica-Worms
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

10.  Chk1 activation requires Rad9 S/TQ-site phosphorylation to promote association with C-terminal BRCT domains of Rad4TOPBP1.

Authors:  Kanji Furuya; Marius Poitelea; Liandi Guo; Thomas Caspari; Antony M Carr
Journal:  Genes Dev       Date:  2004-05-15       Impact factor: 11.361

View more
  48 in total

1.  TopBP1 mediates mutant p53 gain of function through NF-Y and p63/p73.

Authors:  Kang Liu; Shiyun Ling; Weei-Chin Lin
Journal:  Mol Cell Biol       Date:  2011-09-19       Impact factor: 4.272

2.  Molecular basis of BACH1/FANCJ recognition by TopBP1 in DNA replication checkpoint control.

Authors:  Charles Chung Yun Leung; Zihua Gong; Junjie Chen; J N Mark Glover
Journal:  J Biol Chem       Date:  2010-12-02       Impact factor: 5.157

3.  An E2F1-dependent gene expression program that determines the balance between proliferation and cell death.

Authors:  Timothy C Hallstrom; Seiichi Mori; Joseph R Nevins
Journal:  Cancer Cell       Date:  2008-01       Impact factor: 31.743

4.  Miz1 and HectH9 regulate the stability of the checkpoint protein, TopBP1.

Authors:  Steffi Herold; Andreas Hock; Barbara Herkert; Katrien Berns; Jasper Mullenders; Roderick Beijersbergen; Rene Bernards; Martin Eilers
Journal:  EMBO J       Date:  2008-10-16       Impact factor: 11.598

5.  Akt switches TopBP1 function from checkpoint activation to transcriptional regulation through phosphoserine binding-mediated oligomerization.

Authors:  Kang Liu; Joshua D Graves; Jessica D Scott; Rongbao Li; Weei-Chin Lin
Journal:  Mol Cell Biol       Date:  2013-09-30       Impact factor: 4.272

Review 6.  BRCT domains: easy as one, two, three.

Authors:  Charles Chung Yun Leung; J N Mark Glover
Journal:  Cell Cycle       Date:  2011-08-01       Impact factor: 4.534

7.  Mutant p53 perturbs DNA replication checkpoint control through TopBP1 and Treslin.

Authors:  Kang Liu; Fang-Tsyr Lin; Joshua D Graves; Yu-Ju Lee; Weei-Chin Lin
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-24       Impact factor: 11.205

8.  MCPH1/BRIT1 cooperates with E2F1 in the activation of checkpoint, DNA repair and apoptosis.

Authors:  Shan-Zhong Yang; Fang-Tsyr Lin; Weei-Chin Lin
Journal:  EMBO Rep       Date:  2008-07-25       Impact factor: 8.807

9.  14-3-3Tau regulates Beclin 1 and is required for autophagy.

Authors:  Bing Wang; Shiyun Ling; Weei-Chin Lin
Journal:  PLoS One       Date:  2010-04-29       Impact factor: 3.240

10.  Phosphorylation of MLL by ATR is required for execution of mammalian S-phase checkpoint.

Authors:  Han Liu; Shugaku Takeda; Rakesh Kumar; Todd D Westergard; Eric J Brown; Tej K Pandita; Emily H-Y Cheng; James J-D Hsieh
Journal:  Nature       Date:  2010-09-05       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.